RxDoctor Payments Data

Helenmari Merritt, DO

Thoracic Surgery (Cardiothoracic Vascular Surgery) · Omaha, NENPI 1841456498

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $231,080 of the $286,788 with a category attached, or 80.6%. Atricure, Inc. accounts for 87.4% of it on its own, with 27 other manufacturers making up the rest. Reporting peaked in 2022 at $77,397 and has fallen 58.7% since, to $31,940 in 2025. Among thoracic surgery (cardiothoracic vascular surgery) clinicians in NE with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$286,788in general payments, 2019–2025

Across 449 payments — averaging $638.73 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Atricure, Inc.$251K
  • Intuitive Surgical$18K
  • Baxter Healthcare$10K
  • Edwards Lifesciences$2K
  • Medtronic$2K
  • Stryker$1K
  • plus $3K from 22 others
$13,439in research payments, 2019–2025

Across 8 payments — averaging $1679.88 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Atricure, Inc.$13K

What the payments were for

  • Consulting fees$231,08081%
  • Travel & lodging$25,7629%
  • Food & beverage$13,2715%
  • Education$16,6506%
  • Gifts$140%
  • Other$110%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$286,788 in reported general payments places this provider in the 95th percentile of 29 thoracic surgery (cardiothoracic vascular surgery) providers in Nebraska.

See all thoracic surgery (cardiothoracic vascular surgery) providers in Nebraska

Medicare billing

Part B allowed, 2024
$170,124
Medicare patients
179
Services billed
410

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Methylprednisolone12$64

Paid to pharmacies, not to this prescriber.

Other thoracic surgery (cardiothoracic vascular surgery) in Omaha

See the full list for Nebraska

Where these figures come from

Is this you, or does something look wrong? →